Document 0475 DOCN M9480475 TI Oncostatin M activates phosphatidylinositol-3-kinase in Kaposi's sarcoma cells. DT 9410 AU Soldi R; Graziani A; Benelli R; Ghigo D; Bosia A; Albini A; Bussolino F; Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. SO Oncogene. 1994 Aug;9(8):2253-60. Unique Identifier : AIDSLINE MED/94309900 AB Oncostatin M (OM) is a polypeptide cytokine that induces autocrine and paracrine effects on AIDS-Kaposi's sarcoma (KS) cells (Nair et al., Science, 255, 1430-1432, 1992; Miles et al., Science, 255, 1432-1434, 1992). The signalling pathways underlying this activation are largely unknown. We have found that OM binding to KS cell lines in vitro identifies a higher affinity binding site (Kd 10-20 pM) with a lower affinity (Kd 1.5 nM), high capacity binding site. The binding of OM to its receptor at the KS cell surface stimulates a rapid tyrosine phosphorylation of multiple proteins, including the p85 regulatory subunit of phosphatidylinositol-3-kinase (PI3K). In addition OM can stimulate the in vivo activation of PI3K and increases the PI3K activity in anti-phosphotyrosine and anti-src kinase family antibody directed immunoprecipitates. Genistein, an inhibitor of tyrosine kinases, inhibits the synthesis of phosphatidylinositol 3,4-biphosphate and the growth of KS cells. Finally, OM enhances tyrosine kinase activity in immune complex kinase assay performed with antibody anti-src kinase family. These data suggest that in KS cells OM can stimulate formation of tyrosine kinase co-ordinate signalling complexes, containing at least src kinase family and PI3K, which can drive the accumulation of the putative second-messengers D3-phosphorylated phosphoinositides. DE Antineoplastic Agents/*PHARMACOLOGY Cytokines/*PHARMACOLOGY Human Peptides/*PHARMACOLOGY Phosphatidylinositols/METABOLISM Phosphorylation Phosphotransferases (Alcohol Group Acceptor)/*METABOLISM Protein-Tyrosine Kinase/METABOLISM Sarcoma, Kaposi's/*ENZYMOLOGY Support, Non-U.S. Gov't Tumor Cells, Cultured Tyrosine/METABOLISM JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).